The share of scientific publications in drug discovery from the United States among the world's top 10% most-cited publications rose slightly from 15.55% in 2023 to 15.62% in 2024, with projected incremental increases annually, reaching 15.66% by 2028. The year-on-year growth from 2023 to 2024 was minimal, indicative of a stable yet slow increase in influence in this sector over the following years. The five-year compound annual growth rate (CAGR) stands at a modest 0.14%, reflecting marginal advancements in the global share of influential US drug discovery research publications.
Future trends to watch for include the impact of increased federal research funding or policy changes aimed at boosting scientific publication outputs. Also, the adoption of advanced technologies and collaborations with international partners may play a significant role in enhancing the quality and citation count of publications from the US in drug discovery.
